Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114700) titled 'A Multicenter, Randomized, Placebo-Controlled Study on the Efficacy and Safety of Ketotifen in Patients With ST-Segment Elevation Myocardial Infarction' on Dec. 16, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Peking University Third Hospital
Condition:
ST-Segment Elevation Myocardial Infarction
Intervention:
Control Group:Starch placebo
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-01-01
Target Sample Size: Control Group:950;Ketotifen Group:950;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.ht...